Angeles Investment Advisors LLC acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,606 shares of the company’s stock, valued at approximately $514,000. A number of other hedge funds […]